Widespread antibody sequencing and recombinant expression techniques have revolutionized therapeutic antibody development. However, these same innovations are now transforming basic research, setting a new gold standard for high-quality, reproducible antibody reagents. By leveraging sequencing, engineering and expression strategies refined in the biopharmaceutical industry, scientists can generate antibodies with superior qualities to hybridoma-derived or polyclonal antibodies.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Michael
Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack